Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ida

Showing results (271-280 of 277) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 277 results.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Neuro-Oncology|July 27, 2019
Molecular profiling of long-term IDH-wildtype glioblastoma survivorsDanielle M Burgenske, Jie Yang, Paul A Decker, et al.
The Journal of Molecular Diagnostics : JMD|November 9, 2024
SARCP, a Clinical Next-Generation Sequencing Assay for the Detection of Gene Fusions in Sarcomas: A Description of the First 652 CasesMazen A Atiq, Jagadheshwar Balan, Patrick R Blackburn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomasWan-Hsin Lin, Farhad Kosari, James B Smadbeck, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 28

Showing results (271-280 of 277) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 277 results.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Neuro-Oncology|July 27, 2019
Molecular profiling of long-term IDH-wildtype glioblastoma survivorsDanielle M Burgenske, Jie Yang, Paul A Decker, et al.
The Journal of Molecular Diagnostics : JMD|November 9, 2024
SARCP, a Clinical Next-Generation Sequencing Assay for the Detection of Gene Fusions in Sarcomas: A Description of the First 652 CasesMazen A Atiq, Jagadheshwar Balan, Patrick R Blackburn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomasWan-Hsin Lin, Farhad Kosari, James B Smadbeck, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 28